Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform
- Status
- UNKNOWN
- Phase
- N/A
Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
OREIOS International Study
- Status
- COMPLETED
- Phase
- N/A
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
- Status
- UNKNOWN
- Phase
- NA
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
- Status
- COMPLETED
- Phase
- N/A
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
- Status
- RECRUITING
- Phase
- PHASE1
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC
- Status
- UNKNOWN
- Phase
- N/A
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study
- Status
- UNKNOWN
- Phase
- N/A
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Status
- RECRUITING
- Phase
- PHASE3
A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
Multi-analyte Blood Test Clinical Trial
- Status
- RECRUITING
- Phase
- N/A